| 3 | Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401. (Chung DJ, Shah N, Wu J, Logan B, Bisharat L, Callander N, Cheloni G, Anderson K, Chodon T, Dhakal B, Devine S, Somaiya Dutt P, Efebera Y, Geller N, Ghiasuddin H, Hematti P, Holmberg L, Howard A, Johnson B, Karagkouni D, Lazarus HM, Malek E, McCarthy P, McKenna D, Mendizabal A, Nooka A, Munshi N, O'Donnell L, Rapoport AP, Reese J, Rosenblatt J, Soiffer R, Stroopinsky D, Uhl L, Vlachos IS, Waller EK, Young JW, Pasquini MC, Avigan D) Clin Cancer Res 2023 Dec 01;29(23):4784-4796 14 Citations |
| 2 | Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD. (Piper C, Hainstock E, Yin-Yuan C, Chen Y, Khatun A, Kasmani MY, Evans J, Miller JA, Gorski J, Cui W, Drobyski WR) Blood Adv 2022 May 10;6(9):2791-2804 9 Citations |
| 1 | Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target. (Wang X, Lennard Richard M, Li P, Henry B, Schutt S, Yu XZ, Fan H, Zhang W, Gilkeson G, Zhang XK) J Immunol 2021 Jan 01;206(1):59-66 13 Citations |
| 1 | Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD. (Piper C, Zhou V, Komorowski R, Szabo A, Vincent B, Serody J, Alegre ML, Edelson BT, Taneja R, Drobyski WR) Blood 2020 Feb 20;135(8):568-581 33 Citations |
| 1 | Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease. (Denson LA, Jurickova I, Karns R, Shaw KA, Cutler DJ, Okou D, Valencia CA, Dodd A, Mondal K, Aronow BJ, Haberman Y, Linn A, Price A, Bezold R, Lake K, Jackson K, Walters TD, Griffiths A, Baldassano RN, Noe JD, Hyams JS, Crandall WV, Kirschner BS, Heyman MB, Snapper S, Guthery SL, Dubinsky MC, Leleiko NS, Otley AR, Xavier RJ, Stevens C, Daly MJ, Zwick ME, Kugathasan S) Inflamm Bowel Dis 2019 Feb 21;25(3):547-560 9 Citations |
| 3 | Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia. (Erker C, Huppler AR, Walsh TJ, McCormick ME, Suchi M, Bhatt NS, Kehl SC, Southwood J, Harker-Murray P) J Pediatr Hematol Oncol 2018 Oct;40(7):e446-e449 8 Citations |
| 1 | A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma. (Dispenzieri A, D'Souza A, Gertz MA, Laumann K, Wiseman G, Lacy MQ, LaPlant B, Buadi F, Hayman SR, Kumar SK, Dingli D, Hogan WJ, Ansell SM, Gastineau DA, Inwards DJ, Micallef IN, Porrata LF, Johnston PB, Litzow MR, Witzig TE) Bone Marrow Transplant 2017 Oct;52(10):1372-1377 12 Citations |
| 1 | Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. (Harris DM, Hazan-Haley I, Coombes K, Bueso-Ramos C, Liu J, Liu Z, Li P, Ravoori M, Abruzzo L, Han L, Singh S, Sun M, Kundra V, Kurzrock R, Estrov Z) PLoS One 2011;6(6):e21250 31 Citations |
| 1 | Rituximab and CHOP chemotherapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin oncology network study. (Chang JE, Seo S, Kim KM, Werndli JE, Bottner WA, Rodrigues GA, Sanchez FA, Saphner TJ, Longo WL, Kahl BS) Clin Lymphoma Myeloma Leuk 2010 Oct;10(5):379-84 14 Citations |
| 1 | Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients. (Cheng YC, Valero V, Davis ML, Green MC, Gonzalez-Angulo AM, Theriault RL, Murray JL, Hortobagyi GN, Ueno NT) Br J Cancer 2010 Oct 26;103(9):1331-4 8 Citations |
| 1 | Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. (Cheng YC, Rondón G, Sanchez LF, McMannis JD, Couriel DR, de Lima MJ, Hosing C, Khouri IF, Giralt SA, Champlin RE, Ueno NT) Int J Hematol 2009 Dec;90(5):627-634 5 Citations |
| 1 | Autoimmune neutropenia in adults. (Akhtari M, Curtis B, Waller EK) Autoimmun Rev 2009 Sep;9(1):62-6 86 Citations |
| 1 | Pulmonary alveolar proteinosis. (Ioachimescu OC, Kavuru MS) Chron Respir Dis 2006;3(3):149-59 82 Citations |
| 1 | Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. (Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN) J Neurochem 2005 Oct;95(2):437-45 424 Citations |
| 1 | Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms. (Siatskas C, Underwood J, Ramezani A, Hawley RG, Medin JA) FASEB J 2005 Oct;19(12):1752-4 10 Citations |
| 1 | Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses. (Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R) Cancer 2003 Dec 01;98(11):2410-9 21 Citations |
| 1 | Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media. (Shaw PH, Olszewski M, Kletzel M) J Hematother Stem Cell Res 2001 Jun;10(3):391-403 11 Citations |
| 1 | Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia. (Chen X, Regn S, Raffegerst S, Kolb HJ, Roskrow M) Br J Haematol 2000 Nov;111(2):596-607 59 Citations |
| 1 | Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. (Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC) J Clin Oncol 2000 Dec 15;18(24):4077-85 172 Citations |
| 1 | Calcium ionophore upregulation of AUUUA-specific binding protein activity is contemporaneous with granulocyte macrophage colony-stimulating factor messenger RNA stabilization in AML14.3D10 cells. (Ruth JH, Esnault S, Jarzembowski JA, Malter JS) Am J Respir Cell Mol Biol 1999 Nov;21(5):621-8 18 Citations |
| 1 | The 5'-untranslated region of GM-CSF mRNA suppresses translational repression mediated by the 3' adenosine-uridine-rich element and the poly(A) tail. (Jarzembowski JA, Rajagopalan LE, Shin HC, Malter JS) Nucleic Acids Res 1999 Sep 15;27(18):3660-6 12 Citations |
| 1 | Stabilization of granulocyte-macrophage colony-stimulating factor RNA in a human eosinophil-like cell line requires the AUUUA motifs. (Esnault S, Jarzembowski JA, Malter JS) Proc Assoc Am Physicians 1998;110(6):575-84 20 Citations |
| 1 | Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation. (Ferrajoli A, Talpaz M, Kurzrock R, Harris D, Van Q, Estey EH, Estrov Z) Leuk Lymphoma 1998 Jul;30(3-4):279-92 8 Citations |
| 1 | Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia. (Estrov Z, Talpaz M, Ku S, Harris D, Van Q, Beran M, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R) Leuk Res 1998 Apr;22(4):341-53 32 Citations |
| 1 | GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia. (Cortes J, Kantarjian H, O'Brien S, Kurzrock R, Keating M, Talpaz M) Leukemia 1998 Jun;12(6):860-4 51 Citations |
| 1 | Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences. (Gisslinger H, Kurzrock R, Wetzler M, Tucker S, Kantarjian H, Robertson B, Talpaz M) Leuk Lymphoma 1997 Mar;25(1-2):121-33 19 Citations |
| 1 | Increased interleukin-6 production by cerebral cortical tissue of adult versus young mice. (Prechel MM, Halbur L, Devata S, Vaidya AM, Young MR) Mech Ageing Dev 1996 Dec 20;92(2-3):185-94 26 Citations |
| 1 | Interferon-gamma secretion defects in haemophilia A patients receiving highly purified plasma-derived or recombinant factor VIII. (Newton-Nash DK, Tollerud D, Guevarra L, Gill JC) Br J Haematol 1996 Dec;95(3):554-60 6 Citations |
| 1 | Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. (Estrov Z, Talpaz M, Ku S, Harris D, LaPushin R, Koller CA, Hirsh-Ginsberg C, Huh Y, Yee G, Kurzrock R) Leukemia 1996 Sep;10(9):1534-43 17 Citations |
| 1 | Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181). (Estrov Z, Talpaz M, Zipf TF, Kantarjian HM, Ku S, Ouspenskaia MV, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R) J Cell Physiol 1996 Mar;166(3):618-30 27 Citations |
| 3 | Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. (Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR) Blood 1995 Nov 15;86(10):3987-96 59 Citations |
| 1 | Adjuncts to antibacterial therapy. (Frank MO, Mandell GL) Infect Dis Clin North Am 1995 Sep;9(3):769-81 6 Citations |
| 1 | Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. (Estrov Z, Talpaz M, Mavligit G, Pazdur R, Harris D, Greenberg SM, Kurzrock R) Am J Med 1995 Jun;98(6):551-8 67 Citations |
| 2 | Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. (Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F) Blood 1994 Apr 01;83(7):1980-7 125 Citations |
| 1 | Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma. (Wetzler M, Estrov Z, Talpaz M, Markowitz A, Gutterman JU, Kurzrock R) J Intern Med 1993 Oct;234(4):417-20 44 Citations |
| 1 | Suppression of chronic myelogenous leukemia colony growth by interleukin-4. (Estrov Z, Markowitz AB, Kurzrock R, Wetzler M, Kantarjian HM, Ferrajoli A, Gutterman JU, Talpaz M) Leukemia 1993 Feb;7(2):214-20 18 Citations |
| 1 | The effect of granulocyte-macrophage colony-stimulating factor on undifferentiated and mature acute myelogenous leukemia blast progenitors. (Estrov Z, Park CH, Reading CL, Estey EH, Talpaz M, Kurzrock R, Deisseroth AB, Gutterman JU) Exp Hematol 1992 Aug;20(7):886-90 4 Citations |
| 1 | Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia. (Kurzrock R, Talpaz M, Gutterman JU) Am J Med 1992 Jul;93(1):41-8 29 Citations |
| 1 | Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia. (Estrov Z, Estey EH, Andreeff M, Talpaz M, Kurzrock R, Reading CL, Deisseroth AB, Gutterman JU) Exp Hematol 1992 Jun;20(5):558-64 16 Citations |
| 1 | Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF. (Wetzler M, Talpaz M, Kellagher MJ, Gutterman JU, Kurzrock R) JAMA 1992 Apr 22-29;267(16):2179-80 37 Citations |
| 1 | Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. (Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Gutterman JU, Talpaz M) Blood 1992 Apr 15;79(8):1938-45 82 Citations |
| 1 | Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro. (Estrov Z, Kurzrock R, Talpaz M, Blake M, Gutterman JU) Ann Hematol 1991 Dec;63(6):297-301 12 Citations |
| 1 | Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression. (Wetzler M, Kurzrock R, Lowe DG, Kantarjian H, Gutterman JU, Talpaz M) Blood 1991 Nov 01;78(9):2400-6 68 Citations |
| 1 | Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. (Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M) Blood 1991 Sep 15;78(6):1476-84 95 Citations |
| 1 | Treatment of cyclic neutropenia with very low doses of GM-CSF. (Kurzrock R, Talpaz M, Gutterman JU) Am J Med 1991 Sep;91(3):317-8 13 Citations |
| 1 | Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. (Curtis BM, Williams DE, Broxmeyer HE, Dunn J, Farrah T, Jeffery E, Clevenger W, deRoos P, Martin U, Friend D) Proc Natl Acad Sci U S A 1991 Jul 01;88(13):5809-13 146 Citations |
| 1 | Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients. (Kurzrock R, Talpaz M, Gomez JA, Estey EH, O'Brien S, Hirsch-Ginsberg C, Koller C, Freireich EJ, Gutterman JU) Br J Haematol 1991 Jul;78(3):352-8 33 Citations |
| 1 | Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia. (Derfus BA, Csuka ME, Carrera GF, Hanson GA, Smith RE) J Rheumatol 1991 May;18(5):738-42 4 Citations |
| 1 | Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes. (Estey EH, Kurzrock R, Talpaz M, McCredie KB, O'Brien S, Kantarjian HM, Keating MJ, Deisseroth AB, Gutterman JU) Br J Haematol 1991 Mar;77(3):291-5 73 Citations |
| 1 | Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites. (Farmer KL, Kurzrock R, Gutterman JU, Duvic M) Arch Dermatol 1990 Sep;126(9):1243-4 16 Citations |
| 1 | Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defense. (Gutterman J, Vadhan-Raj S, Logothetis C, Anaissle E, Estey E, Talpaz M, Kurzrock R) Semin Hematol 1990 Jul;27(3 Suppl 3):15-24 6 Citations |
| 1 | Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor. (Estey EH, Dixon D, Kantarjian HM, Keating MJ, McCredie K, Bodey GP, Kurzrock R, Talpaz M, Freireich EJ, Deisseroth AB) Blood 1990 May 01;75(9):1766-9 76 Citations |
| 1 | Biological molecules in the treatment of hematological disorders. (Kurzrock R, Talpaz M, Gutterman U) Sangre (Barc) 1989 Feb;34(1):53-8 |
© 2025 Clinical & Translational Science Institute